Optimal pressures and flows during cardiopulmonary bypass. Pro: a low-flow, low-pressure technique is acceptable.

[1]  G. Guiraudon,et al.  Cerebral Autoregulation and Flow/Metabolism Coupling during Cardiopulmonary Bypass: The Influence of Paco2 , 1987, Anesthesia and analgesia.

[2]  R. S. Mitchell,et al.  A prospective, randomized study of the effects of prostacyclin on neuropsychologic dysfunction after coronary artery operation. , 1987, The Journal of thoracic and cardiovascular surgery.

[3]  K. Rådegran,et al.  Somatosensory evoked potentials and cerebral metabolism during cardiopulmonary bypass with special reference to hypotension induced by prostacyclin infusion. , 1985, The Journal of thoracic and cardiovascular surgery.

[4]  L. Smith,et al.  Factors and their influence on regional cerebral blood flow during nonpulsatile cardiopulmonary bypass. , 1984, The Annals of thoracic surgery.

[5]  C. Blomstrand,et al.  Hypotension induced by prostacyclin treatment during cardiopulmonary bypass does not increase the risk of cerebral complications. , 1984, The Journal of thoracic and cardiovascular surgery.

[6]  K. Fish,et al.  NEUROPSYCHOLOGICAL DYSFUNCTION AFTER CORONARY ARTERY SURGERY , 1982 .

[7]  M. Hilberman,et al.  Neurologic dysfunction following cardiac operation with low-flow, low-pressure cardiopulmonary bypass. , 1980, The Journal of thoracic and cardiovascular surgery.

[8]  R. Ellis,et al.  Reduction of flow rate and arterial pressure at moderate hypothermia does not result in cerebral dysfunction. , 1980, The Journal of thoracic and cardiovascular surgery.

[9]  B. Troost,et al.  PaCO2 management during cardiopulmonary bypass: intriguing physiologic rationale, convincing clinical data, evolving hypothesis? , 1990, Anesthesiology.

[10]  G. Bashein,et al.  A randomized study of carbon dioxide management during hypothermic cardiopulmonary bypass. , 1990, Anesthesiology.